$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
ALK阳性肺癌药物赞可达怎么服用
2025-10-19 11:44:20
Check Details
ALK阳性肺癌药物赞可达怎么样
2025-10-19 11:44:20
Check Details
肺癌患者服用阿法替尼后能延长生存期多久?
2025-10-19 11:44:20
Check Details
靶向药阿法替尼(吉泰瑞)图片及简介
2025-10-19 11:44:20
Check Details
阿法替尼吉泰瑞医保报销吗?
2025-10-19 11:44:20
Check Details
靶向药阿法替尼什么时候吃最好?
2025-10-19 11:44:20
Check Details
靶向药阿法替尼多久耐药?
2025-10-19 11:44:20
Check Details
靶向药阿法替尼多少钱一盒?
2025-10-19 11:44:20
Check Details
小细胞肺癌治疗新药卢比替定多少钱
2025-10-19 11:44:20
Check Details
小细胞肺癌治疗新药卢比替定国内有吗
2025-10-19 11:44:20
Check Details
小细胞肺癌治疗新药卢比替定好吗
2025-10-19 11:44:20
Check Details
小细胞肺癌治疗新药卢比替定好用吗
2025-10-19 11:44:20
Check Details
1
2
...
3683
3684
3685
3686
3687
3688
3689
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
2
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
3
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
4
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
5
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
6
Cemiplimab (Libtayo) Drug Information
7
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
8
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
9
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
10
A Revolutionary Targeted Therapy for Hematological Malignancies
11
A New Option for Advanced Renal Cell Carcinoma Treatment
12
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description: